abstract |
The present invention relates to methods of treating CNS disorders, diseases and injuries, particularly neurodegenerative disorders, with cathepsin S inhibitors and with compounds of formula I as cathepsin S inhibitors. The present invention relates to pharmaceutical compositions comprising these compounds for the treatment of CNS disorders. |